Medley Study News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Medley Study. Real-time updates on events, politics, business and more.

Nektar Therapeutics (NASDAQ:NKTR) Q3 2023 Earnings Call Transcript

November 9, 2023

Operator: Good day and thank you for standing by. Welcome to the Nektar Therapeutics Third Quarter 2023 Financial Results Conference Call.

United States San Francisco Jennifer Ruddock Jonathan Zalevsky Vivian Wu Jay Olson

Source: insidermonkey.com

Nektar Therapeutics Reports Second Quarter 2023 Financial Results

August 8, 2023

/PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the second quarter ended June 30, 2023. Cash and investments in...

United States San Francisco David Rosen Vivian Wu Howardw Robin Nektar Therapeutics

Source: prnewswire.com

Nektar Therapeutics (NASDAQ:NKTR) Q1 2023 Earnings Call Transcript

May 10, 2023

Operator: Good day and thank you for standing by. Welcome to the Nektar Therapeutics First Quarter 2023 Financial Results Conference Call.

San Francisco United States Jerry Gong Chris Shibutani Sandra Gardiner Howard Robin

Source: insidermonkey.com

Nektar Therapeutics Announces Strategic Reprioritization and Cost Restructuring Plan

April 17, 2023

-- Pipeline focus will prioritize programs in immunology, including REZPEG and several immunology research programs -- -- Development of NKTR-255 in diffuse...

United States Stanford University San Francisco Eric Lawrence Simpson Kevin Brodbeck Jillian Thomsen